File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1038/cdd.2014.19
- Scopus: eid_2-s2.0-84902277611
- PMID: 24531538
- WOS: WOS:000337234200003
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: IRF4 and BATF are critical for CD8+ T-cell function following infection with LCMV
Title | IRF4 and BATF are critical for CD8<sup>+</sup> T-cell function following infection with LCMV |
---|---|
Authors | Grusdat, M.McIlwain, D. R.Xu, H. C.Pozdeev, V. I.Knievel, J.Crome, S. Q.Robert-Tissot, C.Dress, R. J.Pandyra, A. A.Speiser, D. E.Lang, E.Maney, S. K.Elford, A. R.Hamilton, S. R.Scheu, S.Pfeffer, K.Bode, J.Mittrücker, H. W.Lohoff, M.Huber, M.Häussinger, D.Ohashi, P. S.Mak, T. W.Lang, K. S.Lang, P. A. |
Keywords | LCMV BATF immunopathology hepatitis IRF4 |
Issue Date | 2014 |
Citation | Cell Death and Differentiation, 2014, v. 21, n. 7, p. 1050-1060 How to Cite? |
Abstract | CD8+ T-cell functions are critical for preventing chronic viral infections by eliminating infected cells. For healthy immune responses, beneficial destruction of infected cells must be balanced against immunopathology resulting from collateral damage to tissues. These processes are regulated by 0. CD8+ T-cell function, which are still incompletely understood. Here, we show that the interferon regulatory factor 4 (IRF4) and its cooperating binding partner B-cell-activating transcription factor (BATF) are necessary for sustained CD8+ T-cell effector function. Although Irf4-/- CD8+ T cells were initially capable of proliferation, IRF4 deficiency resulted in limited CD8+ T-cell responses after infection with the lymphocytic choriomeningitis virus. Consequently, Irf4-/- mice established chronic infections, but were protected from fatal immunopathology. Absence of BATF also resulted in reduced CD8+ T-cell function, limited immunopathology, and promotion of viral persistence. These data identify the transcription factors IRF4 and BATF as major regulators of antiviral cytotoxic T-cell immunity. |
Persistent Identifier | http://hdl.handle.net/10722/292829 |
ISSN | 2023 Impact Factor: 13.7 2023 SCImago Journal Rankings: 4.102 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Grusdat, M. | - |
dc.contributor.author | McIlwain, D. R. | - |
dc.contributor.author | Xu, H. C. | - |
dc.contributor.author | Pozdeev, V. I. | - |
dc.contributor.author | Knievel, J. | - |
dc.contributor.author | Crome, S. Q. | - |
dc.contributor.author | Robert-Tissot, C. | - |
dc.contributor.author | Dress, R. J. | - |
dc.contributor.author | Pandyra, A. A. | - |
dc.contributor.author | Speiser, D. E. | - |
dc.contributor.author | Lang, E. | - |
dc.contributor.author | Maney, S. K. | - |
dc.contributor.author | Elford, A. R. | - |
dc.contributor.author | Hamilton, S. R. | - |
dc.contributor.author | Scheu, S. | - |
dc.contributor.author | Pfeffer, K. | - |
dc.contributor.author | Bode, J. | - |
dc.contributor.author | Mittrücker, H. W. | - |
dc.contributor.author | Lohoff, M. | - |
dc.contributor.author | Huber, M. | - |
dc.contributor.author | Häussinger, D. | - |
dc.contributor.author | Ohashi, P. S. | - |
dc.contributor.author | Mak, T. W. | - |
dc.contributor.author | Lang, K. S. | - |
dc.contributor.author | Lang, P. A. | - |
dc.date.accessioned | 2020-11-17T14:57:18Z | - |
dc.date.available | 2020-11-17T14:57:18Z | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | Cell Death and Differentiation, 2014, v. 21, n. 7, p. 1050-1060 | - |
dc.identifier.issn | 1350-9047 | - |
dc.identifier.uri | http://hdl.handle.net/10722/292829 | - |
dc.description.abstract | CD8+ T-cell functions are critical for preventing chronic viral infections by eliminating infected cells. For healthy immune responses, beneficial destruction of infected cells must be balanced against immunopathology resulting from collateral damage to tissues. These processes are regulated by 0. CD8+ T-cell function, which are still incompletely understood. Here, we show that the interferon regulatory factor 4 (IRF4) and its cooperating binding partner B-cell-activating transcription factor (BATF) are necessary for sustained CD8+ T-cell effector function. Although Irf4-/- CD8+ T cells were initially capable of proliferation, IRF4 deficiency resulted in limited CD8+ T-cell responses after infection with the lymphocytic choriomeningitis virus. Consequently, Irf4-/- mice established chronic infections, but were protected from fatal immunopathology. Absence of BATF also resulted in reduced CD8+ T-cell function, limited immunopathology, and promotion of viral persistence. These data identify the transcription factors IRF4 and BATF as major regulators of antiviral cytotoxic T-cell immunity. | - |
dc.language | eng | - |
dc.relation.ispartof | Cell Death and Differentiation | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | LCMV | - |
dc.subject | BATF | - |
dc.subject | immunopathology | - |
dc.subject | hepatitis | - |
dc.subject | IRF4 | - |
dc.title | IRF4 and BATF are critical for CD8<sup>+</sup> T-cell function following infection with LCMV | - |
dc.type | Article | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1038/cdd.2014.19 | - |
dc.identifier.pmid | 24531538 | - |
dc.identifier.pmcid | PMC4207473 | - |
dc.identifier.scopus | eid_2-s2.0-84902277611 | - |
dc.identifier.volume | 21 | - |
dc.identifier.issue | 7 | - |
dc.identifier.spage | 1050 | - |
dc.identifier.epage | 1060 | - |
dc.identifier.eissn | 1476-5403 | - |
dc.identifier.isi | WOS:000337234200003 | - |
dc.identifier.issnl | 1350-9047 | - |